| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |